Immunosuppressants and risk of Parkinson disease

We performed a population‐based case–control study of United States Medicare beneficiaries age 60–90 in 2009 with prescription data (48,295 incident Parkinson disease cases and 52,324 controls) to examine the risk of Parkinson disease in relation to use of immunosuppressants. Inosine monophosphate d...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ann Clin Transl Neurol
Egile Nagusiak: Racette, Brad A., Gross, Anat, Vouri, Scott Martin, Camacho‐Soto, Alejandra, Willis, Allison W., Searles Nielsen, Susan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2018
Gaiak:
Brief Communications
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6043771/
https://ncbi.nlm.nih.gov/pubmed/30009205
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.580
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak